                         SEQUENCE LISTING

<110>  Academisch Ziekenhuis Leiden (h.o.d.n. LUMC)
 
<120>  Immunogenic polypeptides and pharmaceutical compositions

<130>  P308047WO

<150>  NL 2027551
<151>  2021-02-12	

<160>  26    

<170>  PatentIn version 3.5

<210>  1
<211>  46
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Chimeric immunogenic polypeptide

<400>  1

Gln Tyr Ile Lys Ala Asn Ser Lys Phe Ile Gly Ile Thr Glu Leu Lys 
1               5                   10                  15      


Lys Ile Thr Leu Cys Phe Thr Leu Lys Arg Gly Val Gly Tyr Gln Pro 
            20                  25                  30          


Tyr Arg Val Val Val Leu Ser Phe Glu Leu Leu His Ala Pro 
        35                  40                  45      


<210>  2
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  2

Gln Tyr Ile Lys Ala Asn Ser Lys Phe Ile Gly Ile Thr Glu Leu Lys 
1               5                   10                  15      


Lys Tyr Phe Tyr Arg Ser His Arg Ser Thr Lys Leu Lys Pro Phe Glu 
            20                  25                  30          


Arg Asp 
        


<210>  3
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  3

Val His His Asn Thr Glu Glu Ile Val Ala Gln Ser Ile Ala Leu Ser 
1               5                   10                  15      


Ser Leu Met Val Lys Lys Cys Ile Ala Asp Tyr Asn Tyr Lys Leu Pro 
            20                  25                  30          


Asp Asp Phe Thr Gly Cys 
        35              


<210>  4
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  4

Ala Lys Phe Val Ala Ala Trp Thr Leu Lys Ala Ala Ala Lys Lys Gly 
1               5                   10                  15      


Ile Tyr Gln Thr Ser Asn Phe Arg Val Pro Pro Val Arg Phe Pro Asn 
            20                  25                  30          


Ile Thr Asn 
        35  


<210>  5
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  5

Ala Lys Phe Val Ala Ala Trp Thr Leu Lys Ala Ala Ala Lys Lys Phe 
1               5                   10                  15      


Ser Thr Phe Lys Cys Tyr Gly Val 
            20                  


<210>  6
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  6

Ala Lys Phe Val Ala Ala Trp Thr Leu Lys Ala Ala Ala Lys Lys Phe 
1               5                   10                  15      


Ser Thr Phe Lys Cys Tyr Gly Val 
            20                  


<210>  7
<211>  47
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  7

Val His His Asn Thr Glu Glu Ile Val Ala Gln Ser Ile Ala Leu Ser 
1               5                   10                  15      


Ser Leu Met Val Pro Arg Arg Ala Arg Ser Val Ala Ser Gln Ala Ala 
            20                  25                  30          


Cys Ile Leu Pro Asp Pro Ser Lys Pro Ser Lys Arg Ser Phe Cys 
        35                  40                  45          


<210>  8
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  8

Gln Tyr Ile Lys Ala Asn Ser Lys Phe Ile Gly Ile Thr Glu Leu Lys 
1               5                   10                  15      


Lys Ser Thr Pro Cys Asn Gly Val Glu Gly Phe Asn Cys Tyr Phe 
            20                  25                  30      


<210>  9
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  9

Ile Ile Ala Tyr Thr Met Ser Leu Gly Ala Glu Asn Ser Val Ala Tyr 
1               5                   10                  15      


Lys Lys Ser Tyr Gly Gln Pro Thr Asn Gly Val Gly Tyr Gln Tyr Arg 
            20                  25                  30          


<210>  10
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  10

Val His His Asn Thr Glu Glu Ile Val Ala Gln Ser Ile Ala Leu Ser 
1               5                   10                  15      


Ser Leu Met Val Lys Lys Cys Gln Phe Cys Arg Asp Ile Ala Asp Thr 
            20                  25                  30          


Thr Asp Cys Val Arg Asp 
        35              


<210>  11
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  11

Ala Lys Phe Val Ala Ala Trp Thr Leu Lys Ala Ala Ala Lys Lys Cys 
1               5                   10                  15      


Pro Phe Gly Glu Val Phe Asn Ala Thr Arg Phe Ala Ser Val Tyr Ala 
            20                  25                  30          


Trp Asn Arg Lys Arg Ile Ser Asn Cys 
        35                  40      


<210>  12
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  12

Asn Asn Phe Thr Val Ser Phe Trp Leu Arg Val Pro Lys Val Ser Ala 
1               5                   10                  15      


Ser His Leu Glu Thr Lys Lys Met Ser Leu Gly Ala Glu Asn Ser Val 
            20                  25                  30          


Ala Tyr Ser 
        35  


<210>  13
<211>  44
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  13

Asn Ser Val Asp Asp Ala Leu Ile Asn Ser Thr Lys Ile Tyr Ser Tyr 
1               5                   10                  15      


Phe Pro Ser Val Lys Lys Thr Ser Asn Glu Val Ala Val Leu Tyr Gln 
            20                  25                  30          


Gly Val Asn Cys Thr Glu Val Pro Val Ala Ile His 
        35                  40                  


<210>  14
<211>  65
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  14

Ala Lys Phe Val Ala Ala Trp Thr Leu Lys Ala Ala Ala Phe Thr Leu 
1               5                   10                  15      


Lys Arg Gly Val Gly Tyr Gln Pro Tyr Arg Val Val Val Leu Ser Phe 
            20                  25                  30          


Glu Leu Leu His Ala Pro Ala Ala Phe Cys Met Gln Cys Ala Tyr Arg 
        35                  40                  45              


Phe Asn Ala Ala Arg Ser Phe Ile Glu Asp Leu Leu Phe Asn Lys Val 
    50                  55                  60                  


Lys 
65  


<210>  15
<211>  58
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  15

Asn Leu Leu Leu Gln Tyr Gly Ser Phe Ser Thr Gln Leu Asn Arg Lys 
1               5                   10                  15      


Leu Ile Thr Gly Arg Leu Gln Ser Leu Lys Lys Asn Leu Asn Glu Ser 
            20                  25                  30          


Leu Ile Asp Leu Lys Lys Asp Ala Val Asp Cys Ala Leu Asp Pro Leu 
        35                  40                  45              


Ser Glu Thr Lys Cys Thr Leu Lys Ser Phe 
    50                  55              


<210>  16
<211>  60
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  16

Gln Tyr Ile Lys Ala Asn Ser Lys Phe Ile Gly Ile Thr Glu Leu Lys 
1               5                   10                  15      


Lys Ala Leu Pro Asp Thr Pro Ser Thr Leu Thr Pro Arg Ser Val Arg 
            20                  25                  30          


Ser Val Pro Gly Glu Met Arg Leu Ala Ser Ala Ala Cys Arg Lys Gln 
        35                  40                  45              


Leu Ser Pro Leu Glu Gly Gly Gly Trp Leu Val Cys 
    50                  55                  60  


<210>  17
<211>  49
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  17

Tyr Leu Gln Pro Arg Thr Phe Leu Leu Lys Lys Phe Ile Ala Gly Leu 
1               5                   10                  15      


Ile Ala Ile Val Lys Lys Phe Gln Phe Cys Asn Asp Pro Phe Leu Lys 
            20                  25                  30          


Lys Val Val Leu Ser Phe Glu Leu Leu His Ala Pro Ala Thr Val Cys 
        35                  40                  45              


Gly 
    


<210>  18
<211>  51
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  18

Ser Ile Ile Ala Tyr Thr Met Ser Leu Lys Lys Ile Ala Asp Tyr Asn 
1               5                   10                  15      


Tyr Lys Leu Lys Lys Val Leu Asn Asp Ile Leu Ser Arg Leu Lys Lys 
            20                  25                  30          


Ile Asn Ile Thr Arg Phe Gln Thr Leu Leu Ala Leu His Arg Ser Tyr 
        35                  40                  45              


Leu Thr Pro 
    50      


<210>  19
<211>  47
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  19

Leu Leu Phe Asn Lys Val Thr Leu Ala Lys Arg Leu Gln Ser Leu Gln 
1               5                   10                  15      


Thr Tyr Val Lys Lys Val Val Phe Leu His Val Thr Tyr Val Lys Lys 
            20                  25                  30          


Gln Lys Phe Asn Gly Leu Thr Val Leu Pro Pro Leu Leu Thr Asp 
        35                  40                  45          


<210>  20
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  20

Leu Leu Leu Asp Arg Leu Asn Gln Leu Lys Lys Gly Met Ser Arg Ile 
1               5                   10                  15      


Gly Met Glu Val Lys Lys Arg Trp Tyr Phe Tyr Tyr Leu Gly Thr Gly 
            20                  25                  30          


Pro Glu Ala Gly Leu 
        35          


<210>  21
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  21

Phe Leu Ala Phe Val Val Phe Leu Leu Lys Lys Ser Leu Val Lys Pro 
1               5                   10                  15      


Ser Phe Tyr Val Lys Lys Leu Val Thr Leu Ala Ile Leu Thr Ala Leu 
            20                  25                  30          


Arg Leu Cys Ala Tyr 
        35          


<210>  22
<211>  49
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  22

Gly Leu Met Trp Leu Ser Tyr Phe Ile Lys Lys Leu Leu Glu Gln Trp 
1               5                   10                  15      


Asn Leu Val Lys Lys Phe Val Leu Ala Ala Val Tyr Arg Ile Lys Arg 
            20                  25                  30          


Thr Leu Ser Tyr Tyr Lys Leu Gly Ala Ser Gln Arg Val Ala Gly Asp 
        35                  40                  45              


Ser 
    


<210>  23
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  23

Ser Thr Pro Cys Asn Gly Val Lys Gly Phe Asn Cys Tyr Phe Lys Lys 
1               5                   10                  15      


Gln Tyr Ile Lys Ala Asn Ser Lys Phe Ile Gly Ile Thr Glu Leu 
            20                  25                  30      


<210>  24
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  24

Ser Tyr Gly Cys Gln Pro Thr Tyr Gly Val Gly Tyr Gln Cys Tyr Arg 
1               5                   10                  15      


Lys Gln Tyr Ile Lys Ala Asn Ser Lys Phe Ile Gly Ile Thr Glu Leu 
            20                  25                  30          


<210>  25
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  25

Cys Ser Lys Val Gly Gly Asn Tyr Asn Cys Lys Lys Gln Tyr Ile Lys 
1               5                   10                  15      


Ala Asn Ser Lys Phe Ile Gly Ile Thr Glu Leu 
            20                  25          


<210>  26
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial immunogenic polypeptide

<400>  26

Cys Leu Gly Val Tyr Tyr His Lys Asn Asn Lys Ser Trp Met Glu Ser 
1               5                   10                  15      


Glu Phe Cys Lys Lys Gln Tyr Ile Lys Ala Asn Ser Lys Phe Ile Gly 
            20                  25                  30          


Ile Thr Glu Leu 
        35      


